CN113559006A - A cosmetic composition for scavenging free radicals and resisting aging - Google Patents
A cosmetic composition for scavenging free radicals and resisting aging Download PDFInfo
- Publication number
- CN113559006A CN113559006A CN202110672445.4A CN202110672445A CN113559006A CN 113559006 A CN113559006 A CN 113559006A CN 202110672445 A CN202110672445 A CN 202110672445A CN 113559006 A CN113559006 A CN 113559006A
- Authority
- CN
- China
- Prior art keywords
- extract
- composition
- free radicals
- compound
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 239000002537 cosmetic Substances 0.000 title claims abstract description 23
- 230000032683 aging Effects 0.000 title claims abstract description 10
- 230000002000 scavenging effect Effects 0.000 title claims description 7
- -1 imidazo [1, 2-a ] pyridine compound Chemical class 0.000 claims abstract description 34
- 150000003254 radicals Chemical class 0.000 claims abstract description 25
- 239000000284 extract Substances 0.000 claims description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000008367 deionised water Substances 0.000 claims description 10
- 229910021641 deionized water Inorganic materials 0.000 claims description 10
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 229940088594 vitamin Drugs 0.000 claims description 9
- 229930003231 vitamin Natural products 0.000 claims description 9
- 239000000419 plant extract Substances 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- JGOLXXSVKBCQLA-UHFFFAOYSA-N 2-(3,6-dimethylpyrazin-2-yl)-1,3-benzoxazole Chemical compound CC1=CN=C(C)C(C=2OC3=CC=CC=C3N=2)=N1 JGOLXXSVKBCQLA-UHFFFAOYSA-N 0.000 claims description 7
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 7
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 7
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 7
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 7
- 239000003995 emulsifying agent Substances 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 239000003906 humectant Substances 0.000 claims description 6
- 239000002562 thickening agent Substances 0.000 claims description 6
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 5
- 239000004166 Lanolin Substances 0.000 claims description 5
- 241000226556 Leontopodium alpinum Species 0.000 claims description 5
- 230000003712 anti-aging effect Effects 0.000 claims description 5
- 229960000541 cetyl alcohol Drugs 0.000 claims description 5
- 235000019388 lanolin Nutrition 0.000 claims description 5
- 229940039717 lanolin Drugs 0.000 claims description 5
- 229940101267 panthenol Drugs 0.000 claims description 5
- 235000020957 pantothenol Nutrition 0.000 claims description 5
- 239000011619 pantothenol Substances 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- 240000008397 Ganoderma lucidum Species 0.000 claims description 4
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 4
- 229960003237 betaine Drugs 0.000 claims description 4
- 229960005150 glycerol Drugs 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 235000010356 sorbitol Nutrition 0.000 claims description 4
- 241000222336 Ganoderma Species 0.000 claims description 3
- 235000020710 ginseng extract Nutrition 0.000 claims description 3
- 229960004063 propylene glycol Drugs 0.000 claims description 3
- 241000208340 Araliaceae Species 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 241000229143 Hippophae Species 0.000 claims description 2
- 235000003935 Hippophae Nutrition 0.000 claims description 2
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 2
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- 229940024606 amino acid Drugs 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 235000008434 ginseng Nutrition 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims description 2
- 229940118618 leontopodium alpinum extract Drugs 0.000 claims description 2
- 239000011388 polymer cement concrete Substances 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 235000013772 propylene glycol Nutrition 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 14
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 230000009759 skin aging Effects 0.000 abstract description 7
- 230000004792 oxidative damage Effects 0.000 abstract description 4
- 230000002829 reductive effect Effects 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 230000032677 cell aging Effects 0.000 abstract description 2
- 230000003111 delayed effect Effects 0.000 abstract description 2
- 230000001413 cellular effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 150000005234 imidazo[1,2-a]pyridines Chemical class 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- IJYGBBDSLWIIOE-UHFFFAOYSA-N 1,3-oxazole pyrazine Chemical compound N1=CC=NC=C1.O1C=NC=C1 IJYGBBDSLWIIOE-UHFFFAOYSA-N 0.000 description 1
- JXYUJHIUMUUOJM-UHFFFAOYSA-N 2,5-dimethyl-1-oxidopyrazin-1-ium Chemical compound CC1=C[N+]([O-])=C(C)C=N1 JXYUJHIUMUUOJM-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 229910002249 LaCl3 Inorganic materials 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- VDQVEACBQKUUSU-UHFFFAOYSA-M disodium;sulfanide Chemical compound [Na+].[Na+].[SH-] VDQVEACBQKUUSU-UHFFFAOYSA-M 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- FPULFENIJDPZBX-UHFFFAOYSA-N ethyl 2-isocyanoacetate Chemical compound CCOC(=O)C[N+]#[C-] FPULFENIJDPZBX-UHFFFAOYSA-N 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000000799 fusogenic effect Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- ICAKDTKJOYSXGC-UHFFFAOYSA-K lanthanum(iii) chloride Chemical compound Cl[La](Cl)Cl ICAKDTKJOYSXGC-UHFFFAOYSA-K 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/985—Skin or skin outgrowth, e.g. hair, nails
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a cosmetic composition for removing free radicals and resisting aging, which can remove free radicals, reduce oxidative damage, resist cellular oxidative damage and cell aging and effectively play an antioxidant role through the synergistic action of an imidazo [1, 2-a ] pyridine compound and a pyrazine-oxazole biaryl compound. The components are matched with each other, so that the antioxidant capacity of skin tissues can be obviously enhanced, the free radical content of skin is reduced, and the skin aging is delayed.
Description
Technical Field
The invention relates to the technical field of skin care products, in particular to a cosmetic composition for removing free radicals and resisting aging.
Background
Aging is a complex process, which is caused by both internal and external causes. It is believed by the scholars that aging is a result of the production and elimination of free radicals being hindered. Normally, the production and elimination of oxygen radicals in an organism are in relative equilibrium, but certain pathological factors or irradiation with ultraviolet or blue light may increase the formation of oxygen radicals or hinder the capture of free radicals by lutein in human skin. Free radicals can attack, infiltrate, and damage skin cell structures to produce lipid peroxides, ultimately leading to accelerated skin aging.
Therefore, studies on the addition of a radical scavenging component or an antioxidant to a cosmetic composition have been increasing. For example, patent CN102008426A discloses a cosmetic composition with free radical scavenging effect, which comprises flavone extract extracted from apple pomace, yeast extract of reduced glutathione and natural alpha-hydroxy acid extract of alpha-hydroxy acid. Patent CN106727027A discloses a composition for resisting blue light, resisting oxidation and scavenging free radicals, which comprises the following components by mass percent: 0.1-5% of a composition of marigold flower extract and safflower seed oil, 1-10% of tea extract and 1-10% of edelweiss extract. Especially, substances extracted and separated from natural raw materials are added as additives. Patent CN103211729A discloses an anti-aging skin care composition, which comprises elderberry extract, ginkgo leaf extract, pepper extract, scutellaria extract and the like. The above patents all enhance the antioxidant capacity of skin tissues, reduce the free radical content of skin tissues and play a role in delaying skin aging by adding natural plant extracts.
Recent studies have found that imidazo [1, 2-a ] pyridine compounds and pyrazine-oxazole biaryl compounds exhibit excellent antioxidant properties and radical trapping properties. Zhang Ping et al synthesized a series of pyrazine-oxazole biaryl compounds, and tested the antioxidant activity and reducing ability of the compounds by inhibiting free radical-initiated DNA oxidation and quenching free radical reaction systems ("synthesis of pyrazine-oxazole biaryl compounds and their antioxidant properties", Zhang Ping et al, fine chemistry, Vol 37, No. 7, 7/2020). Mathe Gaili and the like are synthesized into imidazo [1, 2-a ] pyridine compounds by a solvent-free method, and the antioxidant activity of the compounds is tested by inhibiting a DNA oxidation reaction system initiated by HO and reduced glutathione free radicals (GS.), the solvent-free synthesis and the antioxidant performance of the imidazo [1, 2-a ] pyridine compounds, the Mathe Gaili and the like, the synthetic chemistry is 2020,28 (3)). However, the prior art does not report that the two are safely applied to skin care products to achieve the effects of resisting oxidation and removing free radicals.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides a cosmetic composition for removing free radicals and resisting aging.
The technical scheme of the invention is as follows:
a cosmetic composition for scavenging free radicals and resisting aging comprises 0.5-2% of imidazo [1, 2-a ] pyridine compound and 0.5-2% of pyrazine-oxazole biaryl compound in percentage by mass.
Preferably, the imidazo [1, 2-a ] pyridine compound is ethyl 2- { (2-phenylimidazo [1, 2-a ] pyridin-3-yl) amino } acetate (formula I). The pyrazine-oxazole biaryl compound is 2- (3, 6-dimethylpyrazin-2-yl) benzoxazole (formula II).
Preferably, the content of ethyl 2- { (2-phenylimidazo [1, 2-a ] pyridin-3-yl) amino } acetate and 2- (3, 6-dimethylpyrazin-2-yl) benzoxazole is 1%, the effect of scavenging free radicals is the best.
The preparation method of the imidazo [1, 2-a ] pyridine compound comprises the following steps: 2-aminopyridine, aromatic aldehyde, ethyl isocyanoacetate and LaCl3 were added to a round bottom flask and reacted for 2h (TLC detection) at 80 deg.C (bath temperature) with stirring. Cooling to room temperature, and purifying by silica gel column chromatography [ eluent: V (ethyl acetate)/V (petroleum ether) ═ 1/3 ].
The preparation method of the pyrazine-oxazole biaryl compound comprises the following steps: 2, 5-dimethylpyrazine-N-oxide, an oxazole compound, anhydrous ferric chloride, 300-sand 400-mesh silica gel and anhydrous 1, 2-dichloroethane are sequentially added into a three-neck round-bottom flask provided with a thermometer and a reflux condenser, and are heated and refluxed for 8 hours at 100 ℃ under the protection of nitrogen (volume fraction is more than 98%). After the reaction is finished, cooling the reaction mixed liquid to room temperature, transferring the reaction mixed liquid to a single-neck flask, and performing rotary evaporation to obtain a powder solid; and using mixed solution of V (petroleum ether) and V (ethyl acetate) as eluent, adopting 300-400 mesh silica gel to carry out column chromatography separation, detecting effluent liquid through Thin Layer Chromatography (TLC), collecting eluent containing the target compound, carrying out rotary evaporation, and drying to obtain the pyrazine-oxazole biaryl compound.
The cosmetic composition of the present invention further comprises a humectant, an emulsifier, a thickener, vitamins, hydrolyzed protein, a plant extract, and deionized water.
Preferably, the cosmetic composition of the invention also comprises 2-10% of humectant, 10-20% of emulsifier, 0.1-0.2% of thickener, 1-3% of vitamin E1, and 5-10% of plant extract.
Wherein the humectant comprises one or more of sorbitol, propylene glycol, glycerol, lanolin, panthenol, cetyl alcohol, amino acid, and betaine;
wherein the emulsifier comprises one or more of polyoxyethylene monostearate, glyceryl monostearate, tween 60, tween 80 and polyoxyethylene monolaurate.
Wherein the thickener comprises one or more of hydroxyethyl cellulose, carboxymethyl cellulose, PMC, xanthan gum, hydroxypropyl cellulose and carrageenan.
Wherein the plant extract comprises one or more of Ginseng radix extract, Ganoderma extract, fructus Hippophae extract, cornu Cervi Pantotrichum extract, and herba Leontopodii Kaempferi extract.
Compared with the prior art, the cosmetic composition provided by the invention has the following beneficial effects:
(1) the composition disclosed by the invention is added with two compounds, through the synergistic effect of the imidazo [1, 2-a ] pyridine compound and the pyrazine-oxazole biaryl compound, free radicals can be removed, oxidative damage is reduced, cell oxidative damage and cell aging are prevented, the antioxidant effect is effectively exerted, and when the composition is applied to cosmetics, the composition can endow the cosmetics with a remarkable anti-aging effect, so that the skin is more delicate, white and moist.
(2) The moisturizing agent added in the components of the invention can lock skin moisture, maintain skin moisture, supplement skin collagen, delay skin aging, and is rich in various nutrition functions by adding the plant extracts, thus having the effects of preventing wrinkles, recovering elasticity, resisting aging and the like on skin. The extract of the alpine edelweiss is also included, so that the skin can be cleaned mildly and deeply, the grease on the epidermis and the dirt in pores can be removed, the skin tension state can be relieved, and the skin can be relieved, calmed, antioxidant, nourished and protected.
(3) The components are matched with each other, so that the antioxidant capacity of skin tissues can be obviously enhanced, the free radical content of skin is reduced, and the skin aging is delayed.
Detailed Description
The invention is further illustrated by the following examples.
Synthesis of Ethyl 12- { (2-phenylimidazo [1, 2-a ] pyridin-3-yl) amino } acetate (A) and pyrazine-oxazole Biarylate as 2- (3, 6-dimethylpyrazin-2-yl) benzoxazole (B)
The two compounds, compound a and compound B, were synthesized by referring to the experimental methods described in "solvent-free synthesis of imidazo [1, 2-a ] pyridine compound and its antioxidant property" (sugao-leyi et al, synthetic chemistry, 2020,28(3)) and "synthesis of pyrazine-oxazole biaryl compound and its antioxidant property" (zhaoxiaping et al, fine chemical engineering, volume 37, phase 7, 2020, 7 months).
1.2 cosmetic compositions
Example 1, a cosmetic composition comprising a composition wherein 1.1 said compound a is synthesized 0.5%, compound B0.5%, sorbitol 2%, glycerin 2%, panthenol 1%, cetyl alcohol 1%, polyoxyethylene monostearate 2%, tween 803%, glyceryl monostearate 10%, hydroxyethyl cellulose 0.2%, sea buckthorn extract 1%, ganoderma lucidum extract 1%, edelweiss extract 5%, vitamin E1%, hydrolyzed protein 3%, the balance deionized water.
Example 2 a cosmetic composition comprising a composition wherein 1.1 said compound a, compound B1, propylene glycol 1, glycerin 2, lanolin 1, betaine 1, polyoxyethylene monolaurate 5, glyceryl monostearate 10, hydroxyethyl cellulose 0.1, xanthan gum 0.05, ginseng extract 1, ganoderma lucidum extract 1, leontopodium alpinum extract 5, vitamin E1.5, hydrolyzed protein 2%, balance deionized water, was synthesized.
Example 3 a cosmetic composition comprising a composition wherein 1.1 said compound a is synthesized 1%, compound B2%, propylene glycol 3%, panthenol 4%, cetyl alcohol 1.5%, lanolin 1.5%, polyoxyethylene monolaurate 10%, glyceryl monostearate 10%, hydroxyethyl cellulose 0.1%, xanthan gum 0.1%, ginseng extract 3%, ganoderma lucidum extract 2%, edelweiss extract 5%, vitamin E2%, hydrolyzed protein 3%, and balance deionized water.
Comparative example 1, which differs from example 2 in that compound a and compound B are not present, made up with deionized water.
Comparative example 2, which differs from example 2 in that it contains only 2% of compound a.
Comparative example 3 differs from example 2 in that it contains only 2% of compound B.
Safety test
The skin irritation test was carried out by dividing 18 healthy rabbits into 3 groups, each group having half male and female, depilating one side of the spinal column of the animal 24 hours before administration with Na2S, applying the compositions of examples 1-3, respectively, and administering for 24 hours, and then removing the composition from the skin with warm water, and no significant skin irritation was observed.
The patch test is mainly used for detecting the irritation of the final cosmetic product or raw material. In examples 1 to 3 of the present invention, a closed patch test of a human body was performed to evaluate the potential skin irritation.
Suitable volunteers were selected 40, and randomly selected in the age range of 18-60 years. 1mL of the liquid sample was added dropwise to the filter paper sheet, which was then placed in a plaque tester. A blank control is set and an equal amount of sample solvent, such as deionized water, is added to the control cuvette well. The test part is selected as the back of a human body, and the spot tester is fixedly attached to the back of the testee by using a non-irritant adhesive tape. The test period lasted 24 h. In order to ensure the accuracy, credibility and scientificity of test results, the volunteers cannot remove the spot tester or make the tested part contact water according to the requirements during the test. And removing the spot tester after 24h, standing for 30min, waiting for the indentation to disappear, and observing the reaction of the skin. If the test result is negative, the test needs to be observed once more at 24h and 48h after the patch test.
The results of the spotting test are shown in Table 1
TABLE 1 Patch test results
"-" ═ negative reactions;
"±" ═ suspicious reaction: only faint erythema;
"+" ═ weak positive reaction (erythema reaction): erythema, infiltration, edema, and possibly pimples;
"+ +", strong positive reaction (herpes response); erythema, infiltration, edema, pimples, herpes; the reaction may be beyond the test area;
"+ + + +" -very strong positive reaction (fusogenic herpes response); obvious erythema, severe infiltration, edema, and fusional herpes; the reaction goes beyond the test area.
As can be seen from table 1, the cosmetic compositions provided in examples 1-3 all produced only 1 suspected reaction in the test. The cosmetic composition provided by the invention is safe and does not bring adverse reactions to human bodies.
Second, anti-aging experiment
Free radicals are intermediates of biochemical reactions during vital activities and can cause skin aging. The anti-aging effect of the compositions of examples 1 to 3 and comparative examples 1 to 3 according to the present invention was evaluated on the effect on DPPH radicals. The detection method comprises the following steps: 3.0mL (0.02mg/mL) of an absolute ethyl alcohol solution of DPPH and 3.0mL (3mg/mL) of an absolute ethyl alcohol diluent of each sample are sequentially added into a 10mL colorimetric tube, absolute ethyl alcohol is added to the mixture to a scale, the mixture is immediately mixed, a 1cm cuvette is used for measuring the light absorption value at the wavelength of 517nm and marking the value as Ai, the mixture is stored in a greenhouse in a dark place for 30min and then the light absorption value is measured and marked as Aj, and a control test is an ethanol solution only added with DPPH, and the light absorption value is marked as Ac. The radical clearance (K) was calculated as follows:
K(%)=[1-(Ai-Aj)/Ac]*100%
the average value of three measurements was taken and the results are shown in Table 2
TABLE 2
Sample (I) | Clearance rate% |
Example 1 | 80.5 |
Example 2 | 89.2 |
Example 3 | 81.3 |
Comparative example 1 | 37.8 |
Comparative example 2 | 76.6 |
Comparative example 3 | 75.3 |
As can be seen from the experimental results of Table 1, the cosmetic composition provided by the present invention can effectively remove free radicals and prevent skin aging. It was surprisingly found that the comparison of example 2 with comparative examples 1 to 3 concluded that the clearance was 89.2% maximum and that the two were synergistic when the content of compound a and compound B was 1%.
Third, stability test
Sample preparation: examples 1 to 3 products
The test method comprises the following steps: internal control standard (illumination for 1 month, high and low temperature test for 3 months); the method comprises the following steps: is higher than the national standard and the industry standard. The test results show that examples 1 to 3 have very good stability.
Fourthly, 60 people try out the composition prepared by the compositions of the embodiments 1 to 3 for 28 days, each group has 20 people, and 95 percent of results show that the composition can obviously improve the skin luster, moisten the face, and has no allergy or stimulation.
The foregoing examples are illustrative of embodiments of the present invention only and are not intended to be limiting in any way; those skilled in the art can make various changes and modifications to the disclosed technology, which are equivalent to those of the embodiments of the present invention, and it is within the scope of the present invention to make various changes and modifications of the invention based on the technical spirit of the present invention.
Claims (9)
1. A cosmetic composition for scavenging free radicals and resisting aging comprises 0.5-2% of imidazo [1, 2-a ] pyridine compound and 0.5-2% of pyrazine-oxazole biaryl compound in percentage by mass.
3. The composition of claim 2, wherein the composition comprises 1% ethyl 2- { (2-phenylimidazo [1, 2-a ] pyridin-3-yl) amino } acetate and 1% 2- (3, 6-dimethylpyrazin-2-yl) benzoxazole.
4. The composition of any one of claims 1-3, further comprising a humectant, an emulsifier, a thickener, a vitamin, a hydrolyzed protein, a plant extract, and deionized water.
5. The composition of claim 4, further comprising 2-10% of a humectant, 10-20% of an emulsifier, 0.1-0.2% of a thickener, 2-2% of vitamin E1, 1-3% of a hydrolyzed protein, 5-10% of a plant extract, and the balance deionized water.
6. The composition of claim 5, wherein the humectant comprises one or more of sorbitol, propylene glycol, glycerin, lanolin, panthenol, cetyl alcohol, amino acids, and betaine; the emulsifier comprises one or more of polyoxyethylene monostearate, glyceryl monostearate, tween 60, tween 80 and polyoxyethylene monolaurate; the thickening agent comprises one or more of hydroxyethyl cellulose, carboxymethyl cellulose, PMC, xanthan gum, hydroxypropyl cellulose and carrageenan; the plant extract comprises one or more of Ginseng radix extract, Ganoderma extract, fructus Hippophae extract, cornu Cervi Pantotrichum extract, and herba Leontopodii Kaempferi extract.
7. The composition of claim 6, wherein the composition consists of: 0.5% of ethyl 2- { (2-phenylimidazo [1, 2-a ] pyridin-3-yl) amino } acetate, 0.5% of 2- (3, 6-dimethylpyrazin-2-yl) benzoxazole, 2% of sorbitol, 2% of glycerol, 1% of panthenol, 1% of cetyl alcohol, 2% of polyoxyethylene monostearate, tween 803, 10% of glyceryl monostearate, 0.2% of hydroxyethyl cellulose, 1% of sea buckthorn extract, 1% of ganoderma lucidum extract, 5% of leontopodium alpinum extract, vitamin E1%, 3% of hydrolyzed protein and the balance of deionized water.
8. The composition of claim 6, wherein the composition consists of ethyl 2- { (2-phenylimidazo [1, 2-a ] pyridin-3-yl) amino } acetate 1%, 2- (3, 6-dimethylpyrazin-2-yl) benzoxazole 1%, propylene glycol 1%, glycerol 2%, lanolin 1%, betaine 1%, polyoxyethylene monolaurate 5%, glyceryl monostearate 10%, hydroxyethyl cellulose 0.1%, xanthan gum 0.05%, ginseng extract 1%, ganoderma extract 1%, edelweiss extract 5%, vitamin E1.5%, hydrolyzed protein 2%, and the balance deionized water.
9. Use of a composition according to any one of claims 1 to 8 for the preparation of a cosmetic for scavenging free radicals and anti-ageing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110672445.4A CN113559006B (en) | 2021-06-17 | 2021-06-17 | A cosmetic composition for scavenging free radicals and resisting aging |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110672445.4A CN113559006B (en) | 2021-06-17 | 2021-06-17 | A cosmetic composition for scavenging free radicals and resisting aging |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113559006A true CN113559006A (en) | 2021-10-29 |
CN113559006B CN113559006B (en) | 2022-09-20 |
Family
ID=78162357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110672445.4A Active CN113559006B (en) | 2021-06-17 | 2021-06-17 | A cosmetic composition for scavenging free radicals and resisting aging |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113559006B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117224418A (en) * | 2023-11-13 | 2023-12-15 | 杭州湃肽生化科技有限公司 | Anti-aging composition and product application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080094459A (en) * | 2007-04-20 | 2008-10-23 | 주식회사 엘지생활건강 | Cosmetic composition having antioxidation activity |
CN105411900A (en) * | 2015-11-26 | 2016-03-23 | 澳宝化妆品(惠州)有限公司 | Leontopodium-alpinum-extract-containing skin caring essence and preparing method thereof |
CN110354028A (en) * | 2018-04-10 | 2019-10-22 | 伽蓝(集团)股份有限公司 | A kind of application of edelweiss extract |
-
2021
- 2021-06-17 CN CN202110672445.4A patent/CN113559006B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080094459A (en) * | 2007-04-20 | 2008-10-23 | 주식회사 엘지생활건강 | Cosmetic composition having antioxidation activity |
CN105411900A (en) * | 2015-11-26 | 2016-03-23 | 澳宝化妆品(惠州)有限公司 | Leontopodium-alpinum-extract-containing skin caring essence and preparing method thereof |
CN110354028A (en) * | 2018-04-10 | 2019-10-22 | 伽蓝(集团)股份有限公司 | A kind of application of edelweiss extract |
Non-Patent Citations (2)
Title |
---|
席高磊 等: "咪唑并[1,2-a]吡啶化合物的无溶剂合成及其抗氧化性能", 《合成化学》 * |
张晓平 等: "吡嗪-噁唑联芳化合物的合成及其抗氧化性能", 《精细化工》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117224418A (en) * | 2023-11-13 | 2023-12-15 | 杭州湃肽生化科技有限公司 | Anti-aging composition and product application thereof |
CN117224418B (en) * | 2023-11-13 | 2024-03-19 | 杭州湃肽生化科技有限公司 | Anti-aging composition and product application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN113559006B (en) | 2022-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20100129689A (en) | Use of a polyphenol-rich plant extract as antioxidant in combination with a hydrating or humectant agent | |
KR101853743B1 (en) | External composition for skin containing Kalopanax pictus (Thunb.) Nakai extract | |
CN113559006B (en) | A cosmetic composition for scavenging free radicals and resisting aging | |
JP4489923B2 (en) | Topical skin preparation | |
KR100361433B1 (en) | Anti-aging cosmetic compositions containing an Extract obtained from Panax ginseng | |
KR100638053B1 (en) | Cosmetic composition for abirritating skin containing extract of rumex crispus as active ingredient | |
JP3657789B2 (en) | Cosmetics | |
KR100864915B1 (en) | Composition comprising mixed extract of japanese apricot and pear blossom having anti-oxidative activity | |
JPH1029927A (en) | Antiaging agent | |
KR101615417B1 (en) | Korean herb cosmetic composition with the anti-oxidant, whitening and ant-inflammatory effect | |
CN113384510B (en) | Fermented composition with anti-photoaging, relieving and cooling effects and preparation method and application thereof | |
KR102645821B1 (en) | Citron fermented extracts and uses thereof | |
KR100530669B1 (en) | Cosmetic Compositions Comprising Lactate and Glycyrrhiza Uralensis Extracts for Skin Whitening | |
KR20000018909A (en) | Wrinkle prevention cosmetic composition containing paecilomyces japonica extract | |
KR20190137329A (en) | Skin external application composition for anti-aging containing Phlox subulata extract | |
KR101154772B1 (en) | Cosmetic composition containing the zizyphus jujuba fruit extract and walnut extract for moisturizing effect on the skin | |
KR100466379B1 (en) | Composition for skin whitening | |
KR20080071386A (en) | Anti-wrinkle cosmetic compositions containing extracts of spica prunellae | |
KR101063147B1 (en) | Compositions containing ginsenosides Ro (ginsenoside Ro) | |
JP2008255043A (en) | Skincare preparation for external use | |
JP4633205B2 (en) | Elastase inhibitor and topical skin preparation | |
KR20180124443A (en) | Cosmetic composition for enhancing skin barrier containing extract of Tremella fuciformis fruiting body | |
JP2005023021A (en) | Elastase inhibitor | |
JP2000256175A (en) | Cosmetic composition | |
KR100558184B1 (en) | A cosmetic composition comprising canna indica extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231214 Address after: D-1296, 2nd Floor, Building 3, No. 30 Shixing Street, Shijingshan District, Beijing, 100043 (Cluster Registration) Patentee after: Beijing Yaxiyan International Trade Co.,Ltd. Address before: 450002 No. 95, Wenhua Road, Henan, Zhengzhou Patentee before: HENAN AGRICULTURAL University |